Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Appl Physiol (1985) ; 109(3): 830-9, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20576841

ABSTRACT

Skeletal muscle weakness is a reported ailment in individuals working in commercial hog confinement facilities. To date, specific mechanisms responsible for this symptom remain undefined. The purpose of this study was to assess whether hog barn dust (HBD) contains components that are capable of binding to and modulating the activity of type 1 ryanodine receptor Ca2+-release channel (RyR1), a key regulator of skeletal muscle function. HBD collected from confinement facilities in Nebraska were extracted with chloroform, filtered, and rotary evaporated to dryness. Residues were resuspended in hexane-chloroform (20:1) and precipitates, referred to as HBDorg, were air-dried and studied further. In competition assays, HBDorg dose-dependently displaced [3H]ryanodine from binding sites on RyR1 with an IC50 of 1.5±0.1 microg/ml (Ki=0.4±0.0 microg/ml). In single-channel assays using RyR1 reconstituted into a lipid bilayer, HBDorg exhibited three distinct dose-dependent effects: first it increased the open probability of RyR1 by increasing its gating frequency and dwell time in the open state, then it induced a state of reduced conductance (55% of maximum) that was more likely to occur and persist at positive holding potentials, and finally it irreversibly closed RyR1. In differentiated C2C12 myotubes, addition of HBD triggered a rise in intracellular Ca2+ that was blocked by pretreatment with ryanodine. Since persistent activation and/or closure of RyR1 results in skeletal muscle weakness, these new data suggest that HBD is responsible, at least in part, for the muscle ailment reported by hog confinement workers.


Subject(s)
Calcium Channel Agonists/pharmacology , Calcium Channel Blockers/pharmacology , Chloroform/chemistry , Dust/analysis , Housing, Animal , Ion Channel Gating/drug effects , Muscle, Skeletal/drug effects , Ryanodine Receptor Calcium Release Channel/drug effects , Solvents/chemistry , Agricultural Workers' Diseases/chemically induced , Animals , Binding Sites , Binding, Competitive , Calcium/metabolism , Calcium Channel Agonists/adverse effects , Calcium Channel Agonists/isolation & purification , Calcium Channel Agonists/metabolism , Calcium Channel Blockers/adverse effects , Calcium Channel Blockers/isolation & purification , Calcium Channel Blockers/metabolism , Cell Line , Chromatography, Thin Layer , Dose-Response Relationship, Drug , Humans , Membrane Potentials , Mice , Muscle Fibers, Skeletal/drug effects , Muscle Fibers, Skeletal/metabolism , Muscle Weakness/chemically induced , Muscle, Skeletal/metabolism , Occupational Health , Rabbits , Risk Assessment , Ryanodine/metabolism , Ryanodine Receptor Calcium Release Channel/metabolism , Sus scrofa
SELECTION OF CITATIONS
SEARCH DETAIL
...